The history of leishmaniasis

D Steverding - Parasites & vectors, 2017 - Springer
In this review article the history of leishmaniasis is discussed regarding the origin of the
genus Leishmania in the Mesozoic era and its subsequent geographical distribution, initial …

Phosphoinositide 3-kinase/Akt signaling and redox metabolism in cancer

N Koundouros, G Poulogiannis - Frontiers in oncology, 2018 - frontiersin.org
Metabolic rewiring and the consequent production of reactive oxygen species (ROS) are
necessary to promote tumorigenesis. At the nexus of these cellular processes is the aberrant …

Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use

GM Nitulescu, D Margina… - International …, 2016 - spandidos-publications.com
Targeted cancer therapies are used to inhibit the growth, progression, and metastasis of the
tumor by interfering with specific molecular targets and are currently the focus of anticancer …

[HTML][HTML] Mechanisms regulating neuromuscular junction development and function and causes of muscle wasting

LA Tintignac, HR Brenner… - Physiological …, 2015 - journals.physiology.org
The neuromuscular junction is the chemical synapse between motor neurons and skeletal
muscle fibers. It is designed to reliably convert the action potential from the presynaptic …

[HTML][HTML] Maximising the potential of AKT inhibitors as anti-cancer treatments

JS Brown, U Banerji - Pharmacology & therapeutics, 2017 - Elsevier
Abstract PI3K/AKT signalling is commonly disrupted in human cancers, with AKT being a
central component of the pathway, influencing multiple processes that are directly involved …

The concise guide to PHARMACOLOGY 2013/14: enzymes

SPH Alexander, HE Benson… - British Journal of …, 2013 - Wiley Online Library
Abstract The Concise Guide to PHARMACOLOGY 2013/14 provides concise overviews of
the key properties of over 2000 human drug targets with their pharmacology, plus links to an …

PDK1: At the crossroad of cancer signaling pathways

PA Gagliardi, A Puliafito, L Primo - Seminars in cancer biology, 2018 - Elsevier
Rational target therapy of cancer would benefit from the identification of new targets that can
be easily inhibited by small molecules. An increasing amount of evidence hints at 3 …

PDK1-SGK1 signaling sustains AKT-independent mTORC1 activation and confers resistance to PI3Kα inhibition

P Castel, H Ellis, R Bago, E Toska, P Razavi… - Cancer cell, 2016 - cell.com
PIK3CA, which encodes the p110α subunit of PI3K, is frequently mutated and oncogenic in
breast cancer. PI3Kα inhibitors are in clinical development and despite promising early …

An overview of kinase downregulators and recent advances in discovery approaches

B Wang, H Wu, C Hu, H Wang, J Liu… - Signal Transduction and …, 2021 - nature.com
Since the clinical approval of imatinib, the discovery of protein kinase downregulators
entered a prosperous age. However, challenges still exist in the discovery of kinase …

Structural insights into protein regulation by phosphorylation and substrate recognition of protein kinases/phosphatases

SH Seok - Life, 2021 - mdpi.com
Protein phosphorylation is one of the most widely observed and important post-translational
modification (PTM) processes. Protein phosphorylation is regulated by protein kinases, each …